Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history.

Literature DB >> 20464532

DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history.

Rodica Pop-Busui¹, William H Herman, Eva L Feldman, Phillip A Low, Catherine L Martin, Patricia A Cleary, Barbara H Waberski, John M Lachin, James W Albers.

Abstract

The DCCT/EDIC (Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications) provides a comprehensive characterization of the natural history of diabetic neuropathy in patients with type 1 diabetes and provides insight into the impact of intensive insulin therapy in disease progression. The lessons learned about the natural history of distal symmetrical polyneuropathy and cardiovascular autonomic neuropathy and the impact of glycemic control on neuropathy are discussed in this review.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20464532 PMCID： PMC3608672 DOI： 10.1007/s11892-010-0120-8

Source DB: PubMed Journal: Curr Diab Rep ISSN： 1534-4827 Impact factor: 4.810

15 in total

1. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors: David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal: N Engl J Med Date: 2005-12-22 Impact factor: 91.245

2. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).

Authors:
Journal: Diabetologia Date: 1998-04 Impact factor: 10.122

3. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.

Authors: T J Orchard; K Y Forrest; D Ellis; D J Becker
Journal: Arch Intern Med Date: 1997-09-08

4. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

Authors:
Journal: Diabetes Care Date: 1999-01 Impact factor: 19.112

5. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors: John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal: N Engl J Med Date: 2000-02-10 Impact factor: 91.245

6. Vascular risk factors and diabetic neuropathy.

Authors: Solomon Tesfaye; Nish Chaturvedi; Simon E M Eaton; John D Ward; Christos Manes; Constantin Ionescu-Tirgoviste; Daniel R Witte; John H Fuller
Journal: N Engl J Med Date: 2005-01-27 Impact factor: 91.245

7. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.

Authors: James W Albers; William H Herman; Rodica Pop-Busui; Eva L Feldman; Catherine L Martin; Patricia A Cleary; Barbara H Waberski; John M Lachin
Journal: Diabetes Care Date: 2010-02-11 Impact factor: 19.112

8. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors: D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal: N Engl J Med Date: 1993-09-30 Impact factor: 91.245

9. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Authors:
Journal: JAMA Date: 2003-10-22 Impact factor: 56.272

10. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial.

Authors:
Journal: Ann Neurol Date: 1995-12 Impact factor: 10.422

46 in total

Review 1. Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

Authors: Megan Jack; Douglas Wright
Journal: Transl Res Date: 2012-01-10 Impact factor: 7.012

Review 2. Retinal Failure in Diabetes: a Feature of Retinal Sensory Neuropathy.

Authors: Ellyn J Gray; Thomas W Gardner
Journal: Curr Diab Rep Date: 2015-12 Impact factor: 4.810

3. Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms.

Authors: L Zilliox; A C Peltier; P A Wren; A Anderson; A G Smith; J R Singleton; E L Feldman; N B Alexander; J W Russell
Journal: Neurology Date: 2011-03-22 Impact factor: 9.910

Review 4. Inflammation: therapeutic targets for diabetic neuropathy.

Authors: Jiyin Zhou; Shiwen Zhou
Journal: Mol Neurobiol Date: 2013-08-30 Impact factor: 5.590

5. Differential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 Diabetes.

Authors: M Luiza Caramori; Youngki Kim; Rama Natarajan; Jason H Moore; Stephen S Rich; Josyf C Mychaleckyj; Ryoko Kuriyama; David Kirkpatrick; Michael Mauer
Journal: J Clin Endocrinol Metab Date: 2015-04-22 Impact factor: 5.958

Review 6. [Insulin therapy of diabetes].

Authors: Monika Lechleitner; Michael Roden; Raimund Weitgasser; Bernhard Ludvik; Peter Fasching; Friedrich Hoppichler; Alexandra Kautzky-Willer; Guntram Schernthaner; Rudolf Prager; Thomas C Wascher
Journal: Wien Klin Wochenschr Date: 2016-04 Impact factor: 1.704

10. Anti-oxidative and anti-inflammatory effects of cinnamaldehyde on protecting high glucose-induced damage in cultured dorsal root ganglion neurons of rats.

Authors: Dan Yang; Xiao-Chun Liang; Yue Shi; Qing Sun; Di Liu; Wei Liu; Hong Zhang
Journal: Chin J Integr Med Date: 2015-11-17 Impact factor: 1.978